{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T22:09:34Z","timestamp":1790374174069,"version":"4.1.0"},"reference-count":17,"publisher":"Informa UK Limited","issue":"4","license":[{"start":{"date-parts":[[2022,5,12]],"date-time":"2022-05-12T00:00:00Z","timestamp":1652313600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"No specific funding"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Scandinavian Journal of Rheumatology"],"published-print":{"date-parts":[[2023,7,4]]},"DOI":"10.1080\/03009742.2022.2063376","type":"journal-article","created":{"date-parts":[[2022,5,12]],"date-time":"2022-05-12T10:08:22Z","timestamp":1652350102000},"page":"412-417","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":5,"title":["Risk of severe COVID-19 in patients with inflammatory rheumatic diseases treated with immunosuppressive therapy in Scotland"],"prefix":"10.1080","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5217-1034","authenticated-orcid":false,"given":"PM","family":"McKeigue","sequence":"first","affiliation":[{"name":"Usher Institute, College of Medicine and Veterinary Medicine, University of Edinburgh, Edinburgh, UK"},{"name":"Public Health Scotland, Glasgow, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8481-5204","authenticated-orcid":false,"given":"D","family":"Porter","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Gartnavel General Hospital, Glasgow, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6558-7189","authenticated-orcid":false,"given":"RJ","family":"Hollick","sequence":"additional","affiliation":[{"name":"Aberdeen Centre for Arthritis and Musculoskeletal Health (Epidemiology Group), School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Aberdeen, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2804-7586","authenticated-orcid":false,"given":"SH","family":"Ralston","sequence":"additional","affiliation":[{"name":"Institute of Genetics and Cancer, College of Medicine and Veterinary Medicine, University of Edinburgh, Western General Hospital Campus, Edinburgh, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3550-1764","authenticated-orcid":false,"given":"DA","family":"McAllister","sequence":"additional","affiliation":[{"name":"Public Health Scotland, Glasgow, UK"},{"name":"Institute of Health and Wellbeing, University of Glasgow, Glasgow, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8345-3288","authenticated-orcid":false,"given":"HM","family":"Colhoun","sequence":"additional","affiliation":[{"name":"Public Health Scotland, Glasgow, UK"},{"name":"Institute of Genetics and Cancer, College of Medicine and Veterinary Medicine, University of Edinburgh, Western General Hospital Campus, Edinburgh, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2022,5,12]]},"reference":[{"key":"cit0001","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-021-02021-5"},{"key":"cit0002","unstructured":"Joint Committee on Vaccination and Immunisation. Joint Committee on Vaccination and Immunisation (JCVI) advice on third primary dose vaccination [Internet]. 2021 [cited 2021 Sep 15]. Available from: https:\/\/www.gov.uk\/government\/publications\/third-primary-covid-19-vaccine-dose-for-people-who-are-immunosuppressed-jcvi-advice\/joint-committee-on-vaccination-and-immunisation-jcvi-advice-on-third-primary-dose-vaccination"},{"key":"cit0003","doi-asserted-by":"publisher","DOI":"10.1016\/S2665-9913(21)00247-2"},{"key":"cit0004","unstructured":"Public Health Scotland. Search criteria for highest risk patients for shielding [Internet]. Public Health Scotland; 2021 [cited 2021 Dec 11]. Report No.: Version 6.0. Available from: https:\/\/hpspubsrepo.blob.core.windows.net\/hps-website\/nss\/3008\/documents\/1_covid-19-search-criteria-highest-risk-patients.pdf"},{"key":"cit0005","unstructured":"Kanani N. Waller E. Caring for people at highest risk during COVID-19 incident [Internet]. Redditch, UK: NHS England; 2020. Available from: https:\/\/www.england.nhs.uk\/coronavirus\/wp-content\/uploads\/sites\/52\/2020\/03\/200321_GP-letter_Annex-2_FINAL_2.pdf"},{"key":"cit0006","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003374"},{"key":"cit0007","unstructured":"National Institute for Health and Care Excellence. Equivalent anti-inflammatory doses: corticosteroids - oral [Internet]. NICE. 2020 [cited 2021 Sep 1]. Available from: https:\/\/cks.nice.org.uk\/topics\/corticosteroids-oral\/background-information\/equivalent-anti-inflammatory-doses\/"},{"key":"cit0008","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a112623"},{"key":"cit0009","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a113439"},{"key":"cit0010","volume-title":"COVID-19 - Identifying patients for shielding in England","author":"British Society for Rheumatology","year":"2020"},{"key":"cit0011","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2521-4"},{"key":"cit0012","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2021-219845"},{"key":"cit0013","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-217871"},{"key":"cit0014","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2021-220418"},{"key":"cit0015","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-218310"},{"key":"cit0016","doi-asserted-by":"publisher","DOI":"10.1111\/dth.15003"},{"key":"cit0017","doi-asserted-by":"publisher","DOI":"10.2139\/ssrn.3910058"}],"container-title":["Scandinavian Journal of Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/03009742.2022.2063376","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T04:11:00Z","timestamp":1686629460000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/03009742.2022.2063376"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,12]]},"references-count":17,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,7,4]]}},"alternative-id":["10.1080\/03009742.2022.2063376"],"URL":"https:\/\/doi.org\/10.1080\/03009742.2022.2063376","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2022.02.13.22270898","asserted-by":"object"}]},"ISSN":["0300-9742","1502-7732"],"issn-type":[{"value":"0300-9742","type":"print"},{"value":"1502-7732","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,12]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=irhe20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=irhe20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2022-04-05","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-05-12","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}